Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Palbociclib Saga: Or Why We Need a Lot of Drug Companies | Main | InterMune Bought »

August 25, 2014

Citable Garbage

Email This Entry

Posted by Derek

Experimental and Clinical Cardiology used to be a reputable journal. Now it's a trash heap piled with crap. No, literally - the Ottawa Citizen newspaper has proof, thanks to reporter Tom Spears (who's an experienced hand at this). The journal was sold last year, and the new owners will publish absolutely anything you send them, as long as you send them $1200 to their bank account in the Turks and Caicos Islands. I wish I were making all that up, but that is exactly how it goes, offshore banking and all.

Spears whipped together a gibberish cardiology paper by taking one about HIV and doing a find-and-replace to substitute "cardiology" for "HIV" wherever it occurred. I'm sure it reads just fine, if you're high on crack. He stripped out all the graphics, wrote up some captions for new ones, but didn't send any graphs or figures with his submission. No problemo, dude! Paper accepted! As soon as the money shows up under that palm tree in the Caribbean, this junk will become the latest contribution to the medical literature.

The "journal" lists an affiliation with the International Academy of Cardiovascular Sciences in Winnipeg, which organization is pretty upset about that, since there's no connection at all any more. But how to get that fixed? The phone number listed for the editorial office doesn't work. And they don't respond to any emails that they don't feel like responding to, which I'd guess are all the ones that don't involve the possibility of $1200 wire transfers.

The wonderful people behind this scam will ride it as long as a shred of reputation clings to the journal's name, or as long as people send them money, whichever comes first. The journal's web site, which I will consider linking to if they pay me twelve hundred dollars, looks legit, except for the slightly-shaky-English-style notice that "Starting from Jan 1, 2013, Experimental and Clinical Cardiology Journal will operate under new publishing group". If you click "Editorial Board", it tells you that a new one is coming soon. And this part is pretty interesting, too - they say that they provide:

. . .outstanding service to authors through a clear and fast editorial process. Review and decision will be fast and our editorial policy is clear: we will either accept your manuscript for publication or not, our editors will not ask for additional research.

All submissions will be peer reviewed, and our reviewers are asked to focus their attention to data presented in the article. Your manuscript, after the review process can be or accepted or declined. Three independent reviewers are reviewing each manuscript and if two of them accept the manuscript then your work will be published without any further corrections. Note that we will not reject a manuscript because it is out of scope or for its perceived importance, novelty or ability to attract citations: we will publish any study that is scientifically sound.

Yeah boy! But as it says under "Publication Fees", "Open access publishing is not without its costs". One of those costs should be the scientific credibility of anyone who sends a paper in to the place these days. I've looked over the most recent papers listed on the web site - there's one from a hospital in Barcelona, a university in Turkey, an institute in China, some group from Italy whose paper doesn't load well, and a bunch of people with German-sounding names whose paper appears to be two pages long and consists of one figure and no text. An erratum? Who can tell? And who would bother? You might as well copy-and-paste some old Star Wars fan-fiction; no one's going to notice. Every single one of these lead authors probably had their paper turn around within a couple of days, and sent $1200 to the flipping Turks and Caicos without batting an eye, for a journal that's supposedly based in Switzerland. For shame.

No getting around it: if you send money to any of the publishers on Beall's List, you are funding a bunch of scam artists. And if you use such a paper to pad your own c.v., then you've decided to become a scam artist yourself.

Comments (8) + TrackBacks (0) | Category: The Dark Side | The Scientific Literature


COMMENTS

1. Anon on August 25, 2014 9:50 AM writes...

The good news is it looks like PubMed stopped indexing these after the Spring of 2013

Permalink to Comment

2. RM on August 25, 2014 3:15 PM writes...

The part that concerns me is the "... used to be a reputable journal." Can we have a moment of silence for the authors who published pre-2013, and now have a paper in a "junk journal" on their CV? Hopefully grant and hiring committees will be understanding of the situation.

I'm also slightly concerned with what will happen when the scam runs it's course, and the publisher yanks the back issues (along with the rest of the website). I'm assuming that there was decent results there, pre-scammer, and losing access to them would be a disappointment. (I guess that's an argument for PubMedCentral-style archival.)

Permalink to Comment

3. worldofchemicals on August 26, 2014 4:26 AM writes...

These not really good how can some post a paper without proper reference and citations it can create serious problems what if some one post a paper which is not yet published or approved, these is totally spam people should not be encourage to do these kind of activity anymore

Permalink to Comment

4. worldofchemicals on August 26, 2014 4:26 AM writes...

These not really good how can some one post a paper without proper reference and citations it can create serious problems what if some one post a paper which is not yet published or approved, these is totally spam people should not be encourage to do these kind of activity anymore

Permalink to Comment

5. Anonymous BMS Researcher on August 26, 2014 9:58 AM writes...

Spears did a followup to his original story a couple weeks later. A couple of those bottom-feeeding journals rejected his first submission for being too short. So he added some paragraphs from an 1851 book about art by Ruskin, and that expanded version was accepted.

Permalink to Comment

6. Shushu on August 26, 2014 2:18 PM writes...

@5: I wonder why they have any sort of standards if the content is meaningless. Do the papers being too short somehow make it more obvious that the journal is bogus? Is it some kind of plausible deniability thing? It seems weird to me because anyone who read more than a sentence of these things would realize that they're bogus. I guess they're banking on that not happening...


On another note, I just got one of those invitations to a fake conference (I actually get a lot of that kind of science spam, and I bet a lot of other readers here do too) on zinc fingers. This one I found to be particularly funny because the word 'zinc' was spelled wrong. I wish I hadn't immediately deleted it so I could remember exactly what the misspelling was, but yeah, it was there.

What's the point of those fake conferences anyway? You pay them money and then you get to say that you went to X conference on topic Y? Is there even a conference, or do you just shell out, do nothing, and get to say you did it?

Permalink to Comment

7. Matt on August 29, 2014 3:33 PM writes...

@6, I always figured those conferences were a not-too-subtle form of expense fraud.

You give them money and, in exchange, you can put a conference presentation on your CV and charge your grant/expense account for a trip somewhere nice. The spam I get is always near some big tourist attraction (Disney World, etc); there's never a bogus conference somewhere in the Badlands....

Permalink to Comment

8. TheSeeker on September 5, 2014 11:41 AM writes...

Why not? exploiting scientists for profit is just so easy. they just roll over like dogs most times.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
The NIH Runs Into Clinical Problems
Paying For Faster Peer Review
Artificial Intelligence For Biology?
Inside Moderna (A Little Bit)
115 Years of JACS Titles
The Brain Is Actually Connected to the Lymphatic System
Solvents and More Solvents
Bristol-Myers Squibb Sues a Former VP